Australia Stock Exchange release from PRESCIENT THERAP : PTX-200 AML Trial Progresses to Higher Dose
22/04/2021 23:38
Australia Stock Exchange release from PRESCIENT THERAP PTX.AX : PTX-200 AML Trial Progresses to Higher Dose
Recent news on Prescient Therapeutics
See all newsAustralia's Prescient Therapeutics falls on discounted share placement
Brief: Prescient Therapeutics Raises A$4.8 Million Via SPP, A$1.2 Million In Placement
Brief: Prescient Therapeutics Says Trading Halt Requested
Australia's Prescient Therapeutics hits near 2-month low on discounted raise
Brief: Prescient Therapeutics Secures EU Authorisation To Commence PTX-100 Clinical Trial